Thibault Mazard

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Édouard Auclin · 1 shared paper, 2023 · strength 0.14
   • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
2. Caterina Vivaldi · 1 shared paper, 2023 · strength 0.14
   • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
3. Lorenzo Pilla · 1 shared paper, 2023 · strength 0.14
   • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
4. Anthony Turpin · 1 shared paper, 2023 · strength 0.14
   • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
5. Volker Kunzmann · 1 shared paper, 2023 · strength 0.14
   • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
6. Sara Lonardi · 1 shared paper, 2023 · strength 0.14
   • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
7. Kathrin Heinrich · 1 shared paper, 2023 · strength 0.14
   • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
8. Alice Boilève · 1 shared paper, 2023 · strength 0.14
   • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
9. Monica Niger · 1 shared paper, 2023 · strength 0.14
   • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
10. Julien Taı̈eb · 1 shared paper, 2023 · strength 0.14
    • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
11. Gerald W. Prager · 1 shared paper, 2023 · strength 0.14
    • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
12. Christoph Benedikt Westphalen · 1 shared paper, 2023 · strength 0.14
    • Paper Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adeno… DOI 10.1016/j.ejca.2023.04.012↗
13. Marc Ychou · 1 shared paper, 2021 · strength 0.13
    • Paper Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma:… DOI 10.1016/j.esmoop.2021.100318↗
14. Eric Assénat · 1 shared paper, 2021 · strength 0.13
    • Paper Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma:… DOI 10.1016/j.esmoop.2021.100318↗
15. Fabienne Portales · 1 shared paper, 2021 · strength 0.13
    • Paper Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma:… DOI 10.1016/j.esmoop.2021.100318↗
16. Christelle de la Fouchardière · 1 shared paper, 2021 · strength 0.13
    • Paper Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma:… DOI 10.1016/j.esmoop.2021.100318↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.